Neurologic autoimmunity and immune checkpoint inhibitors
Elia Sechi(Mayo Clinic), Αναστασία Ζεκερίδου(Mayo Clinic), Divyanshu Dubey(Mayo Clinic in Arizona), A. Sebastian López‐Chiriboga, Eoin P. Flanagan(Mayo Clinic in Arizona), Michelle L. Mauermann(Anna Needs Neuroblastoma Answers), Andrew McKeon(Mayo Clinic), Vanda A. Lennon(Mayo Clinic), Christopher J. Klein(Mayo Clinic), Svetomir N. Markovic(Mayo Clinic in Arizona), Sean J. Pittock(Mayo Clinic), Teerin Liewluck(Mayo Clinic in Arizona)
Cited by 158
Related Papers
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5k
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
Revised diagnostic criteria for neuromyelitis optica
|Neurology|2006|2.6k
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
|The Journal of Experimental Medicine|2005|2.3k
The spectrum of neuromyelitis optica
|The Lancet Neurology|2007|2.2k